ロード中...
Progressive bevacizumab-associated renal thrombotic microangiopathy*
Vascular endothelial growth factor (VEGF) is integral to the integrity of the glomerular filtration barrier. Bevacizumab is a humanized monoclonal antibody directed against VEGF with expanding clinical applications for metastatic solid tumours. We describe a case of a 61-year-old female with ovarian...
保存先:
| 出版年: | NDT Plus |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4421476/ https://ncbi.nlm.nih.gov/pubmed/25949282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndtplus/sfn168 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|